Looming patent cliffs and shrivelling pipelines have pharma's big players looking for new business models that will allow them to increase their bottom lines.
Issue 3 Executive Interviews
Executive Insight: LIMS
Talking with Dave Champagne, Vice President and General Manager, and Kim Shah, Director of Marketing and Business Development, for Informatics at Thermo Fisher Scientific.
“All business organisations will benefit”
Talking with Sparta Systems about the benefits of implementing its TrackWise® quality and compliance management software.
How today’s next generation ELNs can help drive drug discovery
A question and answer session on how Electronic Laboratory Notebooks (ELNs) have evolved over recent years. With ID Business Solutions
The appliance of IT in science
NGP catches up with Geoff Odell, Chairman of the LSIT Global Institute and CIO of the Novartis Genomic Research Institute, to discover how instrumental IT is to the life science drug pipeline.
Biomark my words
Biomarkers are playing an increasingly important role in the development of new drugs to fight disease. In this revealing interview, Dr Werner Kroll, Global Head of Biomarker Development at Novartis, gives us his view on the development of this exciting new area of medicine.
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.